Biosimilars / Nejlevnější knihy
Biosimilars

Kód: 19996239

Biosimilars

Autor Hiten J. Gutka, Harry Yang, Shefali Kakar

This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a developme ... celý popis

4140


Skladem u dodavatele
Odesíláme za 10-13 dnů
Přidat mezi přání

Mohlo by se vám také líbit

Darujte tuto knihu ještě dnes
  1. Objednejte knihu a zvolte Zaslat jako dárek.
  2. Obratem obdržíte darovací poukaz na knihu, který můžete ihned předat obdarovanému.
  3. Knihu zašleme na adresu obdarovaného, o nic se nestaráte.

Více informací

Více informací o knize Biosimilars

Nákupem získáte 414 bodů

Anotace knihy

This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a development path of a new drug, tailored by the mechanism of action, the quality of the molecule, published information on the reference product, the current competitive environment, the target market and regulatory guidance, and most importantly, the emerging totality of evidence for the proposed biosimilar during development. For the ease of readers, the book comprises of six sections as follows: Section I: Business, Health Economics and Intellectual Property Landscape for Biosimilars Section II: Regulatory Aspects of Development and Approval for Biosimilars Section III: Biopharmaceutical Development and Manufacturing of Biosimilars Section IV: Analytical Similarity Considerations for Biosimilars Section V: Clinical aspects of Biosimilar Development Section VI: Biosimilars- Global Development and Clinical Experience Chapters have been written by one or more experts from academia, industry or regulatory agencies who have been involved with one or more aspects of biosimilar product development. The authors and editors have an expertise in commercialization and pricing of biosimilars, intellectual property considerations for biosimilars, chemistry manufacturing controls (CMC) and analytical development for biosimilars, regulatory and clinical aspects of biosimilar development. Besides the industry practitioners, the book includes several contributions from regulators across the globe. The book is edited by Hiten Gutka, Harry Yang and Shefali Kakar.

Parametry knihy

Zařazení knihy Knihy v angličtině Technology, engineering, agriculture Industrial chemistry & manufacturing technologies Industrial chemistry

4140

Oblíbené z jiného soudku



Osobní odběr Praha, Brno a 46876 dalších

Copyright ©2008-26 nejlevnejsi-knihy.cz Všechna práva vyhrazenaSoukromíCookies


Můj účet: Přihlásit se
Všechny knihy světa na jednom místě. Navíc za skvělé ceny.

Nákupní košík ( prázdný )

Vyzvednutí v Balikovně a PPL
boxech
zdarma nad 1 499 Kč.

Nacházíte se: